Loading...

Loading...

Multicare, KalVista to expand oral HAE treatment in Latin America
By MBN Staff - Mon, 01/19/2026 - 08:46
Multicare and KalVista partner to expand access to the first oral on-demand treatment for hereditary angioedema (HAE) across Latin America.
https://mexicobusiness.news/tag/rare-diseases
More Health
The Devastating Impact of a Late Diagnosis in Rare Diseases
By David López García - Tue, 11/25/2025 - 07:00
The rare disease diagnostic odyssey causes years of delay in Mexico, leading to irreversible damage. David López García looks at potential solutions.
AI, Early Breast Detection: The Week in Health
By Sofía Garduño - Thu, 10/23/2025 - 09:03
This week, Mexico highlighted the importance of annual mammograms, PAHO released an AI guide, and b.well partnered with Google.
The Three Pillars of Diagnosis in Rare Diseases
By David López García - Tue, 10/21/2025 - 06:00
Rare diseases suffer long diagnostic delays globally. The solution is to integrate clinic, AI, and algorithms, writes David López García.
Risks, Innovation, Patient Care: The Week in Health
By Sofía Garduño - Thu, 09/18/2025 - 13:41
Mexico’s healthcare sector faces challenges from cyberattacks and rare diseases, but it is strengthening preparations ahead of the 2026 World Cup.
Rare Diseases Affect 10 Million Mexicans: Health Commission
By Aura Moreno - Tue, 09/16/2025 - 10:21
Rare diseases impact up to 10 million Mexicans. Lawmakers call for legal frameworks, registries, and sustainable funding.
Personalized Medicine: A Potential Ally of Mexico’s Health System
By Sofía Garduño - Tue, 08/26/2025 - 13:12
Mexico explores personalized medicine to improve care, cut costs, and position itself as a regional leader in genomics.

Rare Diseases in Mexico: The Path to Timely Diagnosis 
By David López García - Fri, 08/22/2025 - 06:00
David Lopez outlines the challenges of diagnosing rare diseases in Mexico, and highlights the role of AI and industry in improving patient care.
Pembrolizumab Shows 90% Success in Rare Melanoma Trial
By Aura Moreno - Mon, 08/18/2025 - 16:57
A UCLA trial finds pembrolizumab shrinks or eliminates tumors in 90% of desmoplastic melanoma patients.
Novo Nordisk Launches E-Commerce Platform in Mexico
By Sofía Garduño - Wed, 07/23/2025 - 09:57
Novo Nordisk Mexico launches its first Latin American e-commerce store to improve access to therapies for chronic and rare diseases.